ClinTec International Receives Business Innovation Award
News May 22, 2014
ClinTec International has announced as winners of the prestigious ‘Business Innovation of the Year’ award sponsored by Microsoft presented during the Scottish Business Awards, held at the Edinburgh International Conference Centre on the 12th May 2014.
Dr Rabinder Buttar, CEO and Chairman of ClinTec International, was presented the award in a ceremony with over 1,900 business people present. Attending the event was Global Entrepreneur Sir Richard Branson - who earlier met Dr Buttar and said “Well done to the ClinTec team for building an entrepreneurial, innovative global business”.
Sir Richard Branson took part in a live Q&A session hosted by the broadcaster Alastair Stewart. Amongst the many key figures present at the Awards dinner and ceremony were First Minister of Scotland Rt. Honourable Alex Salmond MSP, Secretary of State for Scotland, the Rt. Honourable Alistair Carmichael MP and Chairman of the Awards, Sir Tom Hunter.
Dr Buttar said “ClinTec International is delighted to receive this prestigious award in recognition of all its hard work and dedication. As a global entrepreneurial company, with a presence in over fifty countries, innovation is at the heart of everything that we do”.
First Minister said ClinTec is well recognized as a successful global business operating from Scotland and Dr Buttar as one of our outstanding women in science. Dr Buttar and her International team attended the First Minister’s event at his official residence in Edinburgh, where Professor Andrea Nolan, Principal of Edinburgh Napier, received an honorary OBE by the First Minister on behalf of her Majesty Queen Elizabeth II.
The innovative business idea developed by ClinTec International was the growth of its Academy of Clinical Research Excellence (ACRE). In collaboration with the renowned Edinburgh Napier University, the ClinTec Academy, ACRE has delivered an innovative online Masters Degree programme in International Clinical Research and Technology and so far enrolled students from 15 different countries.
In addition, ACRE now also offers a wide range of other University Certified training courses to address the learning needs globally of all clinical research professionals and through this it is shaping the future of training for clinical researchers on a global scale and driving standards even higher.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018